Skip to content
Toggle Navigation
ABOUT
About Us
Leadership & Board of Directors
Expanded Access
TECHNOLOGY
STERIWAVE
NEWS
INVESTORS
Share Price
Regulatory News
Email Alerts
Reports & Documentation
Corporate Governance
AIM Rule 26
Investor Contacts
CONTACT US
NEWS & ARTICLES
Web Master
2026-05-25T13:58:31-07:00
News
Steriwave ICU Study Outcomes Presented at CSRT2026
Search for:
Top Categories
Toggle Navigation
AMR
COVID-19
Infection Control
Steriwave
Research
Events
Steriwave Now Protecting Patients with Cancer
September 23, 2025
Ondine Presents Major Economic Benefits at ICPIC 2025
September 18, 2025
Steriwave Effective Against C. auris
September 15, 2025
Steriwave Featured on CNBC’s Worldwide Exchange
September 10, 2025
Health Economics Study on Ondine’s Steriwave® Selected for Oral Presentation at ICPIC 2025 in Geneva
September 3, 2025
Ondine Biomedical Launches ABC Medical Center Pilot of Steriwave® Nasal Photodisinfection
August 13, 2025
Former Mexican President to Chair ‘Light Against AMR Initiative’ to Accelerate Photodisinfection Adoption in High-Growth Regions
August 11, 2025
UK Decision to Cancel Fleming Fund Increases Urgency for Innovative Antimicrobial Solutions; Ondine Biomedical Poised to Lead Fight Against Superbugs
July 21, 2025
Groundbreaking ICU Study completed Using Steriwave® Nasal Photodisinfection Technology at Royal Columbian Hospital
July 21, 2025
Previous
2
3
4
Next
Load More Posts
For Media Information
5654 & Company
+44 (0) 0791 7800 011
+44 (0) 0775 7697 357
ondinebiomedical@5654.co.uk
Page load link
Go to Top